Consistently, non-pharmacological inhibition of PP2A prevents MCL1 protein dephosphorylation at Thr-163/Ser-159 in the PEST region and dramatically reduces MCL-1 protein levels in MCL1-amplified lymphoma cells [26]. The gene discussed is PTPA; the disease is lymphoma.